Get weekday updates of Sacramento Bee headlines and breaking news. Sign up here.
A Sacramento biotechnology company is pushing the $500 million California rice industry to a new frontier with a proposal to grow commercial rice engineered to make drug compounds.
The controversial plan is ambitious and somewhat mysterious. The company, Ventria Bioscience, will not reveal where it hopes to cultivate what would be America's first genetically engineered plant-produced pharmaceuticals to reach the market.
Source: http://www.sacbee.com/content/business/agriculture/story/8160152p-9091767c.html
[Editor: The preceding article was not written by A4M/WHN]
